三月 2026
- Home
- EvidentIQ
三月 2026的EvidentIQ市场份额分析
EvidentIQ, a leading provider of end-to-end eClinical and Patient Insights solutions, announced the acquisition of Asthenis GmbH, the market leader in cancer documentation software in the DACH region (Germany, Austria and Switzerland).
EvidentIQ(包含公司地区分支机构)
查看更多网站流量和参与度信息- evidentiq.com
EvidentIQ热门域名的总访问量
了解EvidentIQ市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
EvidentIQ热门域名的平均访问时长
分析EvidentIQ参与度指标。
过去 3 个月的平均访问时长
子公司明细
EvidentIQ热门域名的平均页面浏览量
了解EvidentIQ如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
EvidentIQ 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻EvidentIQ Group recognized as Platinum Pharma Supplier on May 14th '24.EvidentIQ Group is thrilled to announce that EvidentIQ Germany has been recognized as a Platinum Pharma Supplier by Qualifyze's quality compliance program as of May 14, 2024.
八月 22, 2024阅读更多
新闻EvidentIQ Group attends event EUCROF 2024.EvidentIQ Group is at EUCROF 2024 - pushing boundaries and accelerating innovation!
二月 19, 2024阅读更多
查看 EvidentIQ 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。